Approval · Notice of Compliance 880 · 2001
IMURAN: Notice of Compliance 880
Issued August 15, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 880
- Date
- August 15, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMURAN | 00004596 | Marketed |
Medicinal ingredients
- AZATHIOPRINE 50 MG per TAB